Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PALI Palisade Bio > Detailed Quotes

PALI Palisade Bio

0.110
-0.005-4.35%
Close 10/05 16:00 ET
0.115
+0.005+4.55%
Pre Mkt Price 10/06 06:02 ET
High
0.123
Open
0.120
Turnover
582.49K
Low
0.104
Pre Close
0.115
Volume
5.10M
Market Cap
7.84M
P/E(TTM)
0.92
52wk High
3.020
Shares
71.24M
P/E(Static)
Loss
52wk Low
0.090
Float Cap
7.06M
Bid/Ask %
-81.82%
Historical High
792.000
Shs Float
64.20M
Volume Ratio
0.97
Historical Low
0.090
Dividend TTM
--
Div Yield TTM
--
P/B
1.86
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
7.95%
Amplitude
16.51%
Avg Price
0.114
Lot Size
1
Float Cap
7.06M
Bid/Ask %
-81.82%
Historical High
792.000
Shs Float
64.20M
Volume Ratio
0.97
Historical Low
0.090
Dividend TTM
--
P/B
1.86
Dividend LFY
--
Turnover Ratio
7.95%
Amplitude
16.51%
Avg Price
0.114
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
CEO: Dr. Thomas M. Hallam
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...